The announcement was made by the company ahead of the market closing. The stock settled at Rs 536 on the NSE, up Rs 37, or 7% over Friday s closing price. Strides Pharma Science shares also hit their 52-week high of Rs 539.
The Resolution Plan comprising the total Resolution amount of Rs. 3,351 crore has been implemented through Authum Investment & Infrastructure Ltd s subsidiary viz. Reliance Commercial Finance Ltd and RCFL has acquired Business Undertaking of Reliance Home
Zydus Lifesciences Ltd has entered into a BTA for purchase of one of the Business Undertakings of Watson Pharma Pvt Ltd on a going concern basis by way of slump sale, without values being assigned to individual assets and liabilities, on cash-free and deb